PIK3CA Mutations
Oncology·MeSH: Endometrial Neoplasms
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| CGT6297 | Cogent Biosciences, Inc. (COGT) |
Frequently asked questions
How many drugs are in development for PIK3CA Mutations?
BioSniper tracks 1 drug in development for PIK3CA Mutations across 1 company.
How many clinical trials target PIK3CA Mutations?
There are 1 clinical trial targeting PIK3CA Mutations tracked by BioSniper.
Deep-dive into PIK3CA Mutations
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis